Merck, Inc.
🇵🇭Philippines
The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
Phase 4
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 200
- Registration Number
- NCT00002179
- Locations
- 🇺🇸
LAC - USC Med Ctr, Los Angeles, California, United States
🇺🇸Rush Presbyterian - Saint Luke's Med Ctr / Infect Dis, Chicago, Illinois, United States
🇺🇸Beth Israel Deaconess Med Ctr - East Campus, Boston, Massachusetts, United States
The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
Phase 3
Terminated
- Conditions
- First Posted Date
- 2000-08-28
- Last Posted Date
- 2009-12-11
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT00006187
- Locations
- 🇺🇸
Pacific NW Clinical Research Center, Portland, Oregon, United States
🇺🇸University of Rochester, Rochester, New York, United States
🇺🇸Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States
© Copyright 2024. All Rights Reserved by MedPath